Literature DB >> 24336332

Attenuated response of L-type calcium current to nitric oxide in atrial fibrillation.

Nadiia Rozmaritsa1, Torsten Christ, David R Van Wagoner, Hannelore Haase, Johannes-Peter Stasch, Klaus Matschke, Ursula Ravens.   

Abstract

AIM: Nitric oxide (NO) synthesized by cardiomyocytes plays an important role in the regulation of cardiac function. Here, we studied the impact of NO signalling on calcium influx in human right atrial myocytes and its relation to atrial fibrillation (AF). METHODS AND
RESULTS: Right atrial appendages (RAAs) were obtained from patients in sinus rhythm (SR) and AF. The biotin-switch technique was used to evaluate endogenous S-nitrosylation of the α1C subunit of L-type calcium channels. Comparing SR to AF, S-nitrosylation of Ca(2+) channels was similar. Direct effects of the NO donor S-nitroso-N-acetyl-penicillamine (SNAP) on L-type calcium current (ICa,L) were studied in cardiomyocytes with standard voltage-clamp techniques. In SR, ICa,L increased with SNAP (100 µM) by 48%, n/N = 117/56, P < 0.001. The SNAP effect on ICa,L involved activation of soluble guanylate cyclase and protein kinase A. Specific inhibition of phosphodiesterase (PDE)3 with cilostamide (1 µM) enhanced ICa,L to a similar extent as SNAP. However, when cAMP was elevated by PDE3 inhibition or β-adrenoceptor stimulation, SNAP reduced ICa,L, pointing to cGMP-cAMP cross-regulation. In AF, the stimulatory effect of SNAP on ICa,L was attenuated, while its inhibitory effect on isoprenaline- or cilostamide-stimulated current was preserved. cGMP elevation with SNAP was comparable between the SR and AF group. Moreover, the expression of PDE3 and soluble guanylate cyclase was not reduced in AF.
CONCLUSION: NO exerts dual effects on ICa,L in SR with an increase of basal and inhibition of cAMP-stimulated current, and in AF NO inhibits only stimulated ICa,L. We conclude that in AF, cGMP regulation of PDE2 is preserved, but regulation of PDE3 is lost.

Entities:  

Keywords:  Atrial fibrillation; Cyclic nucleotides; L-type calcium current; Nitric oxide; Phosphodiesterases

Mesh:

Substances:

Year:  2013        PMID: 24336332      PMCID: PMC4014863          DOI: 10.1093/cvr/cvt334

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  37 in total

1.  Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling.

Authors:  Claire E Sears; Simon M Bryant; Euan A Ashley; Craig A Lygate; Stevan Rakovic; Helen L Wallis; Stefan Neubauer; Derek A Terrar; B Casadei
Journal:  Circ Res       Date:  2003-03-06       Impact factor: 17.367

2.  The biotin switch method for the detection of S-nitrosylated proteins.

Authors:  S R Jaffrey; S H Snyder
Journal:  Sci STKE       Date:  2001-06-12

3.  Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells.

Authors:  Sergei D Rybalkin; Irina G Rybalkina; Robert Feil; Franz Hofmann; Joseph A Beavo
Journal:  J Biol Chem       Date:  2001-11-26       Impact factor: 5.157

4.  cGMP-dependent protein kinase mediates stimulation of L-type calcium current by cGMP in rabbit atrial cells.

Authors:  Y Wang; M B Wagner; R W Joyner; R Kumar
Journal:  Cardiovasc Res       Date:  2000-11       Impact factor: 10.787

5.  A novel family of S-nitrosothiols: chemical synthesis and biological actions.

Authors:  H H Al-Sa'doni; I Y Khan; L Poston; I Fisher; A Ferro
Journal:  Nitric Oxide       Date:  2000-12       Impact factor: 4.427

Review 6.  Nitric oxide donor drugs: current status and future trends.

Authors:  Ian L Megson; David J Webb
Journal:  Expert Opin Investig Drugs       Date:  2002-05       Impact factor: 6.206

7.  Characterization of effects of endothelin-1 on the L-type Ca2+ current in human atrial myocytes.

Authors:  C Boixel; S Dinanian; L Lang-Lazdunski; J J Mercadier; S N Hatem
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-08       Impact factor: 4.733

8.  Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke.

Authors:  Hua Cai; Zongming Li; Andreas Goette; Fernando Mera; Clegg Honeycutt; Kristian Feterik; Josiah N Wilcox; Samuel C Dudley; David G Harrison; Jonathan J Langberg
Journal:  Circulation       Date:  2002-11-26       Impact factor: 29.690

9.  Cyclic adenosine monophosphate phosphodiesterase type 4 protects against atrial arrhythmias.

Authors:  Cristina E Molina; Jérôme Leroy; Wito Richter; Moses Xie; Colleen Scheitrum; Illkyu-Oliver Lee; Christoph Maack; Catherine Rucker-Martin; Patrick Donzeau-Gouge; Ignacio Verde; Anna Llach; Leif Hove-Madsen; Marco Conti; Grégoire Vandecasteele; Rodolphe Fischmeister
Journal:  J Am Coll Cardiol       Date:  2012-06-12       Impact factor: 24.094

10.  L-type Ca2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices.

Authors:  Xiongwen Chen; Valentino Piacentino; Satoshi Furukawa; Bruce Goldman; Kenneth B Margulies; Steven R Houser
Journal:  Circ Res       Date:  2002-09-20       Impact factor: 17.367

View more
  7 in total

Review 1.  Perspectives and challenges of antioxidant therapy for atrial fibrillation.

Authors:  Iveta Gasparova; Peter Kubatka; Radka Opatrilova; Martin Caprnda; Slavomira Filipova; Luis Rodrigo; Leone Malan; Ioana Mozos; Miroslava Rabajdova; Vladimir Nosal; Nazarii Kobyliak; Vanda Valentova; Daniel Petrovic; Mariusz Adamek; Peter Kruzliak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-11-29       Impact factor: 3.000

Review 2.  Compromised redox homeostasis, altered nitroso-redox balance, and therapeutic possibilities in atrial fibrillation.

Authors:  Jillian N Simon; Klemen Ziberna; Barbara Casadei
Journal:  Cardiovasc Res       Date:  2016-01-19       Impact factor: 10.787

3.  Newly Identified NO-Sensor Guanylyl Cyclase/Connexin 43 Association Is Involved in Cardiac Electrical Function.

Authors:  Pierre-Antoine Crassous; Ping Shu; Can Huang; Richard Gordan; Peter Brouckaert; Paul D Lampe; Lai-Hua Xie; Annie Beuve
Journal:  J Am Heart Assoc       Date:  2017-12-21       Impact factor: 5.501

4.  Reduced density and altered regulation of rat atrial L-type Ca2+ current in heart failure.

Authors:  Richard C Bond; Simon M Bryant; Judy J Watson; Jules C Hancox; Clive H Orchard; Andrew F James
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-06       Impact factor: 4.733

5.  Chloride Channels are Involved in the Development of Atrial Fibrillation - A Transcriptomic and proteomic Study.

Authors:  Yi-Yao Jiang; Hai-Tao Hou; Qin Yang; Xiao-Cheng Liu; Guo-Wei He
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

6.  Neuronal nitric oxide synthase regulation of calcium cycling in ventricular cardiomyocytes is independent of Cav1.2 channel modulation under basal conditions.

Authors:  Janine Ebner; Michal Cagalinec; Helmut Kubista; Hannes Todt; Petra L Szabo; Attila Kiss; Bruno K Podesser; Henrietta Cserne Szappanos; Livia C Hool; Karlheinz Hilber; Xaver Koenig
Journal:  Pflugers Arch       Date:  2019-12-10       Impact factor: 4.458

Review 7.  Therapeutic Implications for PDE2 and cGMP/cAMP Mediated Crosstalk in Cardiovascular Diseases.

Authors:  Mirna S Sadek; Eleder Cachorro; Ali El-Armouche; Susanne Kämmerer
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.